Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Aura Biosciences (AURA) Accumulated Depreciation & Amortization (2020 - 2026)

Aura Biosciences filings provide 7 years of Accumulated Depreciation & Amortization readings, the most recent being $7.3 million for Q1 2026.

  • Quarterly Accumulated Depreciation & Amortization rose 16.69% to $7.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Mar 2026, up 16.69% year-over-year, with the annual reading at $7.1 million for FY2025, 17.81% up from the prior year.
  • Accumulated Depreciation & Amortization hit $7.3 million in Q1 2026 for Aura Biosciences, up from $7.1 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $7.3 million in Q1 2026 and bottomed at $3.0 million in Q1 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $5.2 million, with a median of $5.3 million recorded in 2024.
  • The largest annual shift saw Accumulated Depreciation & Amortization skyrocketed 40.11% in 2023 before it increased 14.68% in 2025.
  • Aura Biosciences' Accumulated Depreciation & Amortization stood at $3.9 million in 2022, then skyrocketed by 30.33% to $5.0 million in 2023, then increased by 18.86% to $6.0 million in 2024, then increased by 17.81% to $7.1 million in 2025, then grew by 3.89% to $7.3 million in 2026.
  • Per Business Quant, the three most recent readings for AURA's Accumulated Depreciation & Amortization are $7.3 million (Q1 2026), $7.1 million (Q4 2025), and $6.8 million (Q3 2025).